Widespread population immunity from prior SARS-CoV-2 infections and vaccinations continues to suppress the risk of a new coronavirus pandemic in 2026, supporting the market's 96.2% implied probability of "No." As of mid-August, CDC data show infections growing in 47 states with an Rt of 1.08, driven by variants such as NB.1.8.1 (Nimbus) and BA.3.2 (Cicada), yet emergency department visits remain very low at 0.4% and overall activity stays far below pandemic thresholds. Official surveillance from the CDC, WHO, and wastewater monitoring indicates seasonal endemic circulation rather than exponential global spread or severe outcomes. A realistic scenario that could shift odds would require a novel variant demonstrating both substantial immune escape and markedly higher virulence, triggering rapid rises in hospitalizations that overwhelm current public health capacity before the year ends.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedNew Coronavirus Pandemic in 2026?
$23,360 Vol.
$23,360 Vol.
$23,360 Vol.
$23,360 Vol.
The resolution source will be official announcements from the World Health Organization.
Market Opened: Jan 6, 2026, 2:40 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Widespread population immunity from prior SARS-CoV-2 infections and vaccinations continues to suppress the risk of a new coronavirus pandemic in 2026, supporting the market's 96.2% implied probability of "No." As of mid-August, CDC data show infections growing in 47 states with an Rt of 1.08, driven by variants such as NB.1.8.1 (Nimbus) and BA.3.2 (Cicada), yet emergency department visits remain very low at 0.4% and overall activity stays far below pandemic thresholds. Official surveillance from the CDC, WHO, and wastewater monitoring indicates seasonal endemic circulation rather than exponential global spread or severe outcomes. A realistic scenario that could shift odds would require a novel variant demonstrating both substantial immune escape and markedly higher virulence, triggering rapid rises in hospitalizations that overwhelm current public health capacity before the year ends.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions